NathanChristopherSteinleMD

PubMed

• TREATMENT OF VITREOMACULAR TRACTION WITH INTRAVITREAL PERFLUOROPROPANE (C3F8) INJECTION.
  Steinle NC, Dhoot DS, Quezada Ruiz C, Castellarin AA, Pieramici DJ, See RF, Couvillion SC, Nasir MA, Avery RL> ;Retina (Philadelphia, Pa.).
• Outcomes by Baseline Choroidal Neovascularization Features in Age-Related Macular Degeneration: A Post Hoc Analysis of the VIEW Studies.
  Steinle, N. C., Du, W., Gibson, A., Saroj, N.> ;Ophthalmology. Retina. 2020 Jul 12
• Phase 1 Study of OPT-302 Inhibition of Vascular Endothelial Growth Factors C and D for Neovascular Age-Related Macular Degeneration.
  Dugel, P. U., Boyer, D. S., Antoszyk, A. N., Steinle, N. C., Varenhorst, M. P., Pearlman, J. A., Gillies, M. C., Finger, R. P., Baldwin, M. E., Leitch, I. M.> ;Ophthalmology. Retina. 2020 Jan 12
• Protecting Vision in Patients With Diabetes With Ultra-Widefield Imaging: A Review of Current Literature.
  Rishi P Singh, Jessica Hsueh, Michael M Han, Ajay E. Kuriyan, Felipe F Conti, Nathan Steinle, Christina Y. Weng, Robert W. Wong, Jose A. Martinez, Charles C. Wykoff> ;Ophthalmic Surgery and Lasers. 2019 Oct 1
• Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Retinopathy: Consequences of Inadvertent Treatment Interruptions.
  Thomas J. Wubben, Mark W. Johnson, Elliott H. Sohn, James J. Peairs, Christine N. Kay, Stephen J. Kim, Thomas W. Gardner, Yannis M. Paulus, David N. Zacks, Nathan C. S...> ;American Journal of Ophthalmology. 2019 Aug 1
• The Intersection of Diabetes Mellitus and Cataract Surgery: Current State of Management.
  Steinle NC, Lampen SIR, Wykoff CC> ;Ophthalmology. Retina. 2017-12-22
• Current Treatment Options for the Management of Vitreomacular Traction.
  Dilsher S Dhoot, Seenu M. Hariprasad, Nathan C Steinle> ;Ophthalmic Surgery and Lasers. 2017 May 1
• LARGE SILICONE DROPLETS AFTER INTRAVITREAL BEVACIZUMAB (AVASTIN).
  Avery, R. L., Castellarin, A. A., Dhoot, D. S., Pieramici, D. J., Nasir, M. A., Steinle, N. C., Avery, L. P., Gordon, G. M.> ;Retinal cases & brief reports. 2017 Mar 17
• 1 citation
  SYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB.
  Avery, R. L., Castellarin, A. A., Steinle, N. C., Dhoot, D. S., Pieramici, D. J., See, R. F., Couvillion, S., Nasir, M. A., Rabena, M. D., Maia, M., Van Everen, S., Le...> ;Retina (Philadelphia, Pa.). 2017 Jan 21
• Residual edema evaluation with ranibizumab 0.5 mg and 2.0 mg formulations for diabetic macular edema (REEF study).
  Dhoot, D. S.,Pieramici, D. J.,Nasir, M.,Castellarin, A. A.,Couvillion, S.,See, R. F.,Steinle, N.,Bennett, M.,Rabena, M.,Avery, R. L.> ;Eye (Lond). 2015 Jan 31
• Retinal infiltrates secondary to metastatic squamous cell carcinoma masquerading as infectious retinitis.
  Rishi P Singh, Nathan Steinle, Rumneek Bedi, Peter K. Kaiser, Careen Y. Lowder> ;Retinal Cases & Brief Reports. 2014 Oct 1
• 70 citations
  Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD.
  Avery, R. L., Castellarin, A. A., Steinle, N. C., Dhoot, D. S., Pieramici, D. J., See, R. F., Couvillion, S., Nasir, M. A., Rabena, M. D., Le, K., Maia, M., Visich, J. E.> ;The British journal of ophthalmology. 2014 Jul 9
• Rate of hypotony following 25-gauge pars plana vitrectomy.
  Naina Gupta, Omar S. Punjabi, Nathan Steinle, Rishi P Singh> ;Ophthalmic Surgery and Lasers. 2013 Feb 19
• Oral rifampin utilisation for the treatment of chronic multifocal central serous retinopathy
  Nathan Steinle, Naina Gupta, Alex Yuan, Rishi P Singh> ;British Journal of Ophthalmology. 2012 Jan 1
• Join now to see all